P1.25. Enhanced Assessment Of Recurrence Risk Of Stage I NSCLC By Combined Adenocarcinoma Grading System And Serum Proteomic Testing - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Harvey Pass
Meta Tag
Speaker Harvey Pass
Topic Early-Stage NSCLC: Changing Paradigms & Outcomes
recurrence risk assessment
stage I non-small cell lung cancer
adenocarcinoma grading system
serum proteomic testing
stratification of recurrence risk
personalized treatment protocols
mass spectrometry
circulating proteome
machine learning
ternary recurrence risk stratification test
Powered By